Spots Global Cancer Trial Database for Breath Test for Early Detection of Lung Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Breath Test for Early Detection of Lung Cancer
Official Title: Breath Test Assay for the Adjunctive Detection of Lung Cancer
Study ID: NCT00639067
Conditions
Interventions
Study Description
Brief Summary: To demonstrate and validate a breath test for detection of early stage lung cancer that could potentially reduce number of deaths.
Detailed Description: This is a multicenter study comparing several groups of subjects with and without lung cancer by CT scan, biopsy and the breath test. The breath test will be performed to validate the methodology and the predictive algorithm that were previously developed.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: Yes
Locations
Christiana Hospital, Newark, Delaware, United States
MD Anderson Cancer Center, Orlando, Florida, United States
New York University Medical Center, New York, New York, United States
Swedish Cancer Institute, Seattle, Washington, United States
Contact Details
Name: Michael Phillips, MD, FACP
Affiliation: Menssana Research, Inc.
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
